Imoxicate 100 mg/25 mg spot-on solution for medium dogs

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

Aktif bileşen:

Imidacloprid; Moxidectin

Mevcut itibaren:

Krka, d.d., Novo mesto

ATC kodu:

QP54AB52

INN (International Adı):

Imidacloprid; Moxidectin

Doz:

100,25 mg/pipette

Farmasötik formu:

Spot-on solution

Reçete türü:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapötik alanı:

moxidectin, combinations

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

2020-03-13

Ürün özellikleri

CONFIDENTIAL
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Imoxicate 100 mg/25 mg spot-on solution for medium dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 1 ml pipette contains:
ACTIVE SUBSTANCES:
Imidacloprid
100 mg
Moxidectin
25 mg
EXCIPIENTS:
Butylhydroxytoluene (E 321)
1 mg
Benzyl alcohol (E 1519)
807 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Spot-on solution.
Clear, slightly yellow to yellow or to brownish yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Medium dogs (>4-10 kg).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For dogs suffering from, or at risk from, mixed parasitic infections:
The treatment and prevention of flea infestation (
_Ctenocephalides felis_
),
The treatment of biting lice (
_Trichodectes canis_
),
The treatment of ear mite infestation (
_Otodectes cynotis_
), sarcoptic mange (caused by
_Sarcoptes_
_scabiei _
var.
_canis_
), demodicosis (caused by
_Demodex canis_
),
The prevention of heartworm disease (L3 and L4 larvae of
_Dirofilaria immitis_
),
Treatment of circulating microfilariae (
_Dirofilaria immitis_
),
The treatment of cutaneous dirofilariosis (adult stages of
_Dirofilaria repens_
),
The prevention of cutaneous dirofilariosis (L3 larvae of
_Dirofilaria repens_
),
The reduction of circulating microfilariae (
_Dirofilaria repens_
),
The prevention of angiostrongylosis (L4 larvae and immature adults of
_Angiostrongylus vasorum_
),
The treatment of
_Angiostrongylus vasorum _
and
_Crenosoma vulpis_
,
The prevention of spirocercosis (
_Spirocerca lupi_
),
The treatment of
_Eucoleus _
(syn.
_Capillaria_
)
_boehmi _
(adults),
The treatment of the eye worm
_Thelazia callipaeda _
(adults),
Treatment of infections with gastrointestinal nematodes (L4 larvae,
immature adults and adults of
_Toxocara canis, Ancylostoma caninum _
and
_Uncinaria stenocephala_
, adults of
_Toxascaris leonina _
and
_Trichuris vulpis_
).
The product can be used as part of a treatment strategy for flea
allergy dermatitis (FAD).
2
CONFIDENTIAL
4.3
CONTRA